Cytokine modulators as novel therapies for airway disease

Barnes P.J.

Source: Eur Respir J 2001; 18: 67S-77S
Journal Issue: July 2001 - Suppl. 34
Disease area: Airway diseases

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Barnes P.J.. Cytokine modulators as novel therapies for airway disease. Eur Respir J 2001; 18: 67S-77S

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
T-helper cell type-1 transcription factor T-bet is upregulated in pulmonary sarcoidosis
Source: Eur Respir J 2011; 38: 1136-1144
Year: 2011



A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation
Source: Eur Respir J 2008; 31: 783-789
Year: 2008



IL-18 and IL-12 induce inflammatory cytokines, chemokine ligand 9 (CXCL9) and T cell infiltration in pulmonary tissue
Source: Annual Congress 2011 - Lung cell injury and repair
Year: 2011


Chemokinome characterization in human lung macrophages following stimulation with Th2-type cytokines IL-4 or IL-13
Source: Annual Congress 2012 - Update on neutrophil and macrophage function in COPD
Year: 2012

Endotoxin-induced release of the Th17-associated cytokine interleukin (IL)-26 in human neutrophils
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017

Cytokines in asthma
Source: Eur Respir J 2001; 18: 24S-33S
Year: 2001



Interleukin-18, interleukin-12, interferon γ and interleukin-18 receptor expression is decreased in the recovery phase of pulmonary sarcoidosis
Source: Eur Respir J 2001; 18: Suppl. 33, 366s
Year: 2001

Interleukin (IL-13) modulates allergen-induced airway hyperresponsiveness by a pathway independent of IL-5 or eotaxin in mice
Source: Eur Respir J 2003; 22: Suppl. 45, 194s
Year: 2003

Decreased levels of CXC angiogenic chemokines (IL-8, ENA-78 and GRO-α) in BALF after interferon gamma-1b treatment in IPF patients
Source: Eur Respir J 2005; 26: Suppl. 49, 267s
Year: 2005

Upregulated response to chemokines in oxidative metabolism of eosinophils in asthma and allergic rhinitis
Source: Eur Respir J 2003; 21: 925-931
Year: 2003



Decreased T-bet expression and changes in levels of chemokines (IP-10, MIG, RANTES, MCP-1 and IL-8) in peripheral blood of adults with asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 593s
Year: 2006

Pro- and anti-inflammatory cytokines TNF-alpha, IFN-gamma, IL-10 and TGF-beta1 levels in blood serum as markers of plasmaferesis success and inflammation activity in lung sarcoidosis (LS)
Source: Eur Respir J 2006; 28: Suppl. 50, 676s
Year: 2006

Lung expression of interleukin-13 (IL-13) and interferon gamma (IFNg) in emphysema in human
Source: Eur Respir J 2002; 20: Suppl. 38, 584s
Year: 2002

LSC - 2019 - IL-4, IL-8, IL-13, IL-17, IL-33 serum levels changes in acute allergic asthma model
Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease
Year: 2019

dsRNA enhances eotaxin-3 production through interleukin-4 receptor upregulation in airway epithelial cells
Source: Eur Respir J 2005; 26: 795-803
Year: 2005



Levels of interleukins IL-4, IL-6, IL-8 and TNFa in sera of patients with tuberculosis before and during treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 556s
Year: 2002

Regulation of cytokine expression in human plasmacytoid dendritic cells by prostaglandin I2 analogues
Source: Eur Respir J 2009; 33: 405-410
Year: 2009



Influence of montelukast on T cell migration, production of Th2-type cytokines and proinflammatory cytokines
Source: Eur Respir J 2004; 24: Suppl. 48, 129s
Year: 2004